Services



Nutraceutical Products



Search Knowledge Base



TeleClasses & Events




The Cancer Coach



Subscribe to
     Morph2Health




Home
    
Dr. James partners with persons with cancers and other serious illnesses to construct a "whole person" roadmap leading to health and well-being. To immediately receive a free copy of my groundbreaking book, Conquer Your Fear of Cancer, click here now to sign up for a free homepage.




Behavioral Oncology Definitions -> Autologous Communications: The Autocrine/Paracrine Languages -> Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering?

Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering?

In spite of extensive investigation, the mechanism for cell cytotoxicity of the anthracycline antitumor drug adriamycin (ADR) has not yet been completely understood but the nature of the cytotoxic effects of this drug is generally related to its interaction with nuclear components, such as DNA and topoisomerase II. In a previous paper, we studied, using Confocal Laser Scanning Microscopy (CLSM), the localization of ADR and its glutathione (GSH)-conjugate (ADRIGLU), obtained by the anaerobic reaction of the parent anthracycline with reduced GSH, in drug-sensitive and in multidrug resistant (MDR) cells. In all drug-sensitive lines used, ADR was mostly located in the nuclei, while its GSH-conjugate was found only in the cytoplasm, predominantly in the Golgi region. In this study we examined the morphological changes induced by ADR or its GSH-conjugated adduct (ADRIGLU) treatments in TVM-A12 (clone 2) melanoma and K562 erythroleukemia human cell lines, correlated to programmed cell death (apoptosis). We observed that ADR-induced apoptosis in both cell lines tested after 5 h treatment: CLSM and Scanning Electron Microscopy (SEM) showed cell shrinkage, fragmentation and condensation of nuclear chromatin, cell surface blebbing and cytoplasmic vacuolization. On the contrary, ADRIGLU-induced fragmentation and condensation of nuclear chromatin, typical of apoptosis, only after 48-72 h treatment. Cytoflourimetric assay by propidium iodide staining confirmed the data obtained by CLSM and SEM. Our data suggest that apoptosis activation by anthracycline antitumor drugs is induced not only by direct interaction with nuclear components but also with cytoplasmic compartments.

Serafino A, Sinibaldi-Vallebona P, Pierimarchi P, Bernard P, Gaudiano G, Massa C, Rasi G, Ranagnan G.

Institute of Experimental Medicine, Research Area of Rome Tor Vergata, National Research Council, Italy.

PMID: 10470135[PubMed Citation]



Homepage | About ATO | Contact ATO | Privacy Policy | Terms and Conditions
Send Questions or Comments to info@james-arond-thomas.com
Contact Dr. James Today: (734) 973-8700.

© 2001-2006 James A. Arond-Thomas, M.D. All Rights Reserved. This content may be copied in full, with copyright, contact, creation and information intact, without specific permission, when used only in a not-for-profit format. If any other use is desired, permission in writing from Dr. Arond-Thomas is required.

Disclaimer: The entire contents of this website are based upon the opinions of Dr. Arond-Thomas, unless otherwise noted. Individual articles are based upon the opinions of the respective author, who retains copyright as marked. The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of Dr. Arond-Thomas and his community. Dr. Arond-Thomas encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional.
Arond-Thomas Online Sitemap